industry sentiment
Enough evidence
Current company news
Industry news sentiment
Biotechnology news sentiment
This is a global view using qualified companies from every covered country.
News score51.5Neutral is 50
More positive than negative
53/100 company breadth
66/100 confidence
633 companies with usable readings from 1096 current records
Current reading
Company news is mixed
Positive and negative company readings are balancing each other. The company list below shows where they differ.
What supports this score
88% of the stories are tied directly to a company.
What limits this score
Confidence is 66/100, so this group score should be treated cautiously.
Only 46% of measured companies had a positive one-week price move.
Company breadth
How widely the direction is shared
53Breadth
Constructive558.7%
Balanced55888.2%
Cautious203.2%
Score distribution
How company scores are spread
1Strong caution
19Cautious
558Balanced
51Constructive
4Strongly constructive
Evidence quality
How reliable the score is
66/100 group confidence
High confidence346
Usable evidence91
Developing196
17890 company-news stories across 6648 publishers. 88% is tied directly to a company.
13-week history
News score and company breadth
18 May29 Jun10 Aug
News scoreCompany breadthNeutral 50
The chart follows the same set of up to 180 current companies. Later headlines do not change earlier stored readings.
Price check
How company prices moved after the news
Price is shown beside the news score. It never changes the news score.
Group breakdown
Countries in this industry
Highest scores
🇧🇷 Brazil54.79 companies · 66/100 confidence🇦🇹 Austria52.68 companies · 62/100 confidence🇮🇳 India51.911 companies · 73/100 confidence🇸🇪 Sweden51.728 companies · 59/100 confidence🇦🇺 Australia51.642 companies · 70/100 confidence🇺🇸 United States51.6313 companies · 67/100 confidence🇧🇪 Belgium51.55 companies · 62/100 confidence🇭🇰 Hong Kong51.454 companies · 61/100 confidenceLowest scores
🇲🇽 Mexico48.510 companies · 66/100 confidence🇨🇭 Switzerland48.98 companies · 60/100 confidence🇮🇱 Israel49.910 companies · 70/100 confidence🇯🇵 Japan50.424 companies · 50/100 confidence🇫🇷 France50.617 companies · 59/100 confidence🇨🇦 Canada51.08 companies · 61/100 confidence🇬🇧 United Kingdom51.222 companies · 65/100 confidence🇨🇳 China51.345 companies · 57/100 confidence8 groups are not shown because fewer than 5 companies have a score.
Further breakdown
Sectors containing this industry
Highest scores
Healthcare51.5633 companies · 66/100 confidenceLowest scores
Healthcare51.5633 companies · 66/100 confidenceGroup comparison
How this group compares
Oil & Gas Midstream56.169/100 confidence · 78 equitiesInvestment Banking & Investment Services56.076/100 confidence · 1 equitiesSemiconductor Equipment & Materials55.561/100 confidence · 114 equitiesOil & Gas Refining & Marketing55.264/100 confidence · 74 equitiesLumber & Wood Production51.658/100 confidence · 45 equitiesOther Industrial Metals & Mining51.571/100 confidence · 535 equitiesBiotechnology51.566/100 confidence · 633 equitiesGrocery Stores51.566/100 confidence · 59 equitiesResorts & Casinos51.564/100 confidence · 42 equitiesConsumer Electronics50.164/100 confidence · 66 equitiesHomebuilding & Construction Supplies50.069/100 confidence · 1 equitiesDiversified Telecommunication Services50.056/100 confidence · 1 equitiesSoftware38.047/100 confidence · 1 equities
News subjects
Most common subjects
Market update41465.4% of companies · score 52.0
Earnings19430.6% of companies · score 51.1
Deals and strategy101.6% of companies · score 52.3
Regulatory and legal71.1% of companies · score 36.9
Analyst action40.6% of companies · score 54.9
Guidance40.6% of companies · score 54.3
Publishers
Where the latest stories came from
TradingView13922.0% of companies · score 51.3
TradingKey6310.0% of companies · score 52.3
Stock Titan386.0% of companies · score 50.8
MarketBeat355.5% of companies · score 51.9
simplywall.st345.4% of companies · score 51.4
TipRanks304.7% of companies · score 51.0
marketscreener.com233.6% of companies · score 51.7
Kalkine223.5% of companies · score 51.3
Summary
Coverage and score spread
Score rank#126among 154 measured industries
Parent spread-0.7versus Healthcare
Score spread4.6higher values mean companies differ more
Companies
The companies used in this score
Constructive leaders
AUTL70
Autolus Therapeutics Ltd
News confirmed by price · +41.6% 1W
Earnings · 53/100 confidence · 30 direct storiesB1ME3470
BeOne Medicines AG
Balanced read · +0.0% 1W
Earnings · 48/100 confidence · 4 direct storiesRNXT67
RenovoRx Inc
News confirmed by price · +16.9% 1W
Earnings · 53/100 confidence · 34 direct storiesOABI66
OmniAb Inc.
News confirmed by price · +55.6% 1W
Earnings · 38/100 confidence · 34 direct storiesBMRN64
Biomarin Pharmaceutical Inc
News confirmed by price · +6.3% 1W
Earnings · 46/100 confidence · 44 direct storiesACAD63
ACADIA Pharmaceuticals Inc
News confirmed by price · +12.9% 1W
Earnings · 53/100 confidence · 59 direct storiesARGX62
argenx NV ADR
Positive news being faded · -7.0% 1W
Earnings · 80/100 confidence · 46 direct storiesABVX62
Abivax SA American Depositary Shares
Balanced read · -0.6% 1W
Earnings · 80/100 confidence · 44 direct storiesCautious laggards
ERAS32
Erasca Inc
Bad news being absorbed · +1.4% 1W
Regulatory and legal · 72/100 confidence · 91 direct storiesSPRY35
ARS Pharmaceuticals, Inc
Bad news being absorbed · +20.1% 1W
Regulatory and legal · 63/100 confidence · 35 direct storiesADMA36
ADMA Biologics Inc
Bad news being absorbed · +2.3% 1W
Regulatory and legal · 80/100 confidence · 49 direct storiesREPL36
Replimune Group Inc
Bad news being absorbed · +7.7% 1W
Regulatory and legal · 75/100 confidence · 78 direct storiesHUMA36
Humacyte Inc
Bad news being absorbed · +9.9% 1W
Earnings · 56/100 confidence · 31 direct storiesALNY37
Alnylam Pharmaceuticals Inc
Bad news being absorbed · +6.7% 1W
Earnings · 52/100 confidence · 70 direct storiesMIST37
Milestone Pharmaceuticals Inc
Bad news being absorbed · +9.9% 1W
Earnings · 43/100 confidence · 25 direct storiesANNX38
Annexon Inc
Bad news being absorbed · +6.2% 1W
Earnings · 45/100 confidence · 49 direct storiesMost evidence
VRTX60
Vertex Pharmaceuticals Inc
News confirmed by price · +4.0% 1W
Earnings · 61/100 confidence · 114 direct storiesERAS32
Erasca Inc
Bad news being absorbed · +1.4% 1W
Regulatory and legal · 72/100 confidence · 91 direct storiesREPL36
Replimune Group Inc
Bad news being absorbed · +7.7% 1W
Regulatory and legal · 75/100 confidence · 78 direct storiesAXSM51
Axsome Therapeutics Inc
Balanced read · -2.4% 1W
Earnings · 54/100 confidence · 74 direct storiesALNY37
Alnylam Pharmaceuticals Inc
Bad news being absorbed · +6.7% 1W
Earnings · 52/100 confidence · 70 direct storiesINSM61
Insmed Inc
News confirmed by price · +33.0% 1W
Earnings · 53/100 confidence · 70 direct storiesIONS44
Ionis Pharmaceuticals Inc
Price moving ahead of tone · +9.3% 1W
Earnings · 42/100 confidence · 64 direct storiesSANA53
Sana Biotechnology Inc
Balanced read · -1.6% 1W
Market update · 75/100 confidence · 60 direct storiesLatest company readings
Recent company news scores
BLTE53
Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance
seekingalpha.com · Market update · Balanced read
42/100 confidence · 96% direct evidenceDNLI53
Denali Therapeutics (DNLI) Q2 2026 Earnings Call Transcript
nasdaq.com · Earnings · Price moving ahead of tone
39/100 confidence · 93% direct evidenceRCKT53
RCKT (RCKT) insider Martin Wilson plans sale of 3,493 vested shares
Stock Titan · Earnings · Price moving ahead of tone
46/100 confidence · 97% direct evidenceSPRY35
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
finance.yahoo.com · Regulatory and legal · Bad news being absorbed
63/100 confidence · 96% direct evidencePTCT59
PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy
MedCity News · Earnings · News confirmed by price
45/100 confidence · 94% direct evidenceOVID59
Ovid Therapeutics (NASDAQ:OVID) Announces Earnings Results, Beats Estimates By $0.02 EPS
MarketBeat · Earnings · News confirmed by price
43/100 confidence · 100% direct evidenceMNPR40
Monopar Therapeutics Shares Drop After Downgrade From Cantor Fitzgerald
marketscreener.com · Market update · Bad news being absorbed
41/100 confidence · 100% direct evidenceOBIO48
Wall Street Analysts Are Bullish on Top Healthcare Picks
The Globe and Mail · Earnings · Price moving ahead of tone
46/100 confidence · 93% direct evidenceREPL36
Bronstein, Gewirtz & Grossman, LLC Is Investigating Replimune Group Inc. (REPL) And Encourages Shareholders to Connect
The National Law Review · Regulatory and legal · Bad news being absorbed
75/100 confidence · 97% direct evidenceMIRM45
Janus Henderson Group (MIRM) reports 5.9M Mirum Pharma shares under management
Stock Titan · Earnings · Price moving ahead of tone
49/100 confidence · 97% direct evidenceIMMX43
Janus Henderson Group (IMMX) discloses 9.78M-share beneficial stake in Immix Biopharma
Stock Titan · Market update · Price moving ahead of tone
44/100 confidence · 98% direct evidenceJANX44
Janus Henderson Group (JANX) reports 172,229 Janux Therapeutics shares under management
Stock Titan · Earnings · Price moving ahead of tone
41/100 confidence · 96% direct evidenceHUMA36
H.C. Wainwright Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $4
Moomoo · Earnings · Bad news being absorbed
56/100 confidence · 100% direct evidenceRLAY48
Relay Therapeutics Stock Is Up Nearly 500% Over the Past Year
Barchart.com · Earnings · Price moving ahead of tone
45/100 confidence · 100% direct evidenceKYTX60
Kyverna Therapeutics advances autoimmune drug mivocabtagene autoleucel with strong trial results and regulatory progress.
Pluang · Earnings · News confirmed by price
40/100 confidence · 100% direct evidenceMGX43
Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall Street · Earnings · Balanced read
37/100 confidence · 99% direct evidenceAXSM51
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Simply Wall Street · Earnings · Balanced read
54/100 confidence · 96% direct evidenceCRBP48
Mizuho lowers Corbus Pharmaceuticals stock price target on model updates By Investing.com
Investing.com Australia · Earnings · Price moving ahead of tone
42/100 confidence · 97% direct evidenceHow it works
How to read this page
The score measures positive and negative company news after relevance, publisher quality, subject importance and freshness weighting. 50 is neutral.
Breadth shows how many companies share the same direction. A few extreme scores cannot make breadth look strong.
Confidence uses the amount of news, direct company matches, publisher variety, freshness and agreement. It is separate from direction.
Completed weekly prices show whether prices moved with or against the news. Price never changes the news score.
Company readings that do not pass the checks are excluded. A subgroup needs at least five companies before it is ranked.
This page describes current published news. It is not a forecast, price target or recommendation.